Median Technologies

Median Technologies was founded in 2002 by Fredrik Brag, Gerard Milhiet, and Arnaud Butzbach. The company is based in Valbonne, France, and specializes in developing advanced medical imaging software. Their mission is to transform the field of medical imaging by leveraging cutting-edge technology to improve the early diagnosis and monitoring of diseases, particularly cancer.

In its journey, Median Technologies has focused on integrating artificial intelligence into its imaging solutions, aiming to provide more accurate and efficient diagnostic tools for healthcare professionals. This focus on innovation has positioned the company as a leader in the medical imaging industry.

A significant milestone for Median Technologies was its Initial Public Offering (IPO) on Euronext in May 2025. This event marked a new chapter for the company, providing it with the capital needed to expand its research and development efforts and to enhance its market presence globally.

In addition to the IPO, Median Technologies has successfully secured multiple funding rounds, including a notable €11.6 million equity fundraising in July 2023. These financial boosts have enabled the company to continue its pioneering work in medical imaging and to explore new opportunities in the healthcare sector.

Today, Median Technologies stands at the forefront of medical imaging innovation, committed to improving patient outcomes through technological advancements. The company's journey reflects a dedication to pushing the boundaries of what is possible in healthcare technology.